Related Experiment Video
Updated: Jun 24, 2026

Synthesis of an In vivo MRI-detectable Apoptosis Probe
Published on: July 31, 2012
Induction of apoptosis promoted by Bang52; a small molecule that downregulates Bcl-x(L)
Matteo Rossi1, Jeong-Kyu Bang, Sharlyn Mazur
1Laboratory of Cell Biology, NCI, NIH, Bethesda, MD 20892, USA.
Abstract:
Cancer cells evade death by over-producing specific proteins that inhibit apoptosis. One such group of proteins is the Bcl-2 family, of which Bcl-x(L) is an important member. This protein binds and inhibits BAK, another protein that promotes apoptosis. While the development of chemical inhibitors that block Bcl-x(L)-BAK association have been the focus of intense research efforts, we demonstrate in this manuscript an alternative strategy to downregulate Bcl-x(L). We have identified a small molecule (Bang52) that induces apoptosis in a lymphoblast-derived cell line by lowering levels of Bcl-x(L). Since Bang52 bears no resemblance to any chemical binder of Bcl-x(L) we believe that degradation of the protein is stimulated by a new type of pathway. These findings highlight a novel approach to the development of small molecules that promote apoptosis.
Insights
This study introduces Bang52, a novel small molecule that triggers cancer cell death by reducing levels of the anti-apoptotic protein Bcl-xL. This discovery offers a new strategy for developing apoptosis-inducing cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- Cancer cells resist apoptosis by over-producing anti-apoptotic proteins like Bcl-xL.
- Bcl-xL inhibits apoptosis by binding to and blocking the pro-apoptotic protein BAK.
- Targeting Bcl-xL-BAK interactions is a key strategy in cancer therapy development.
Purpose of the Study:
- To investigate an alternative strategy for downregulating Bcl-xL in cancer cells.
- To identify novel small molecules that induce apoptosis via a new mechanism.
- To explore the potential of Bang52 as an apoptosis-inducing agent.
Main Methods:
- Identification of a small molecule, Bang52.
- Assessment of Bang52's effect on Bcl-xL protein levels.
- Evaluation of Bang52's ability to induce apoptosis in a lymphoblast-derived cell line.
Main Results:
- Bang52 was identified as a small molecule that induces apoptosis.
- Bang52 treatment led to decreased levels of Bcl-xL.
- The mechanism of action for Bang52 appears to involve protein degradation via a novel pathway.
Conclusions:
- Bang52 represents a novel approach to downregulating Bcl-xL.
- This study highlights a new pathway for small molecule-induced protein degradation.
- Bang52 shows potential for developing new apoptosis-promoting cancer therapeutics.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
